Stockreport

Eli Lilly lowers insulin costs as coronavirus crisis deepens [Reuters]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Eli Lilly lowers insulin costs as coronavirus crisis deepens (Reuters) - Drugmaker Eli Lilly & Co said on Tuesday it has capped the out-of-pocket cost for insulin to $35 [Read more]